Financhill
Back

Ikena Oncology Stock Predictions

Ikena Oncology Stock Forecast

  • Is Ikena Oncology Stock Undervalued?
    The current Ikena Oncology [IKNA] share price is $1.56. The Score for IKNA is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • IKNA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Ikena Oncology Stock Go Up Next Year?

Data Unavailable

Ikena Oncology Stock Rating

Data Unavailable

Ikena Oncology Stock Price History

Is IKNA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IKNA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ikenaoncology.com

52-Week Data

52-Week High:
2.30
52-Week Low:
1.22

Prediction Charts

Market Cap:
75.3M
Price in USD:
1.56
Volume:
207.2K
Beta:
0.50

Technical Analysis

SMA50:
1.69
SMA100:
1.69
SMA200:
1.60
52-Wk Change:
-20%

Stock Predictions

  • Is Ikena Oncology stock public?
    Yes, Ikena Oncology is a publicly traded company.
  • What is the Ikena Oncology stock quote today?
    The Ikena Oncology stock price is 1.56 USD today.
  • How to buy Ikena Oncology stock online?
    You can buy Ikena Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 1.69 1.70 1.71 1.67
Dec-4 1.67 1.70 1.70 1.67
Dec-5 1.66 1.68 1.69 1.65
Dec-6 1.68 1.68 1.71 1.66
Dec-9 1.67 1.67 1.69 1.62
Dec-10 1.67 1.70 1.71 1.65
Dec-11 1.70 1.70 1.71 1.69
Dec-12 1.70 1.66 1.70 1.65
Dec-13 1.69 1.65 1.69 1.63
Dec-16 1.66 1.61 1.67 1.56
Dec-17 1.60 1.62 1.63 1.54
Dec-18 1.60 1.55 1.61 1.52
Dec-19 1.55 1.61 1.64 1.52
Dec-20 1.62 1.56 1.62 1.56

Ikena Oncology Earnings

Data Unavailable

Ikena Oncology Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.08 per share.

* Ikena Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.